We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Great Southern Bancorp
GSBC
$878M
| $3.48M | ﹤0.01% |
54,916
+11,379
| +26% | +$688K |
|
|
GTHX
2177
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $3.48M | ﹤0.01% |
131,547
-1,841
| -1% | -$43.1K |
|
|
PEI
2178
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $3.48M | ﹤0.01% |
20,556
| – | – |
|
2179
Gerdau
GGB
$9.7B
| $3.46M | ﹤0.01% |
890,552
-1,790,014
| -67% | -$5.32M |
|
2180
Triumph Financial Inc
TFIN
$1.82B
| $3.46M | ﹤0.01% |
90,937
-47
| -0.1% | -$1.62K |
|
|
BFYT
2181
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $3.46M | ﹤0.01% |
179,151
-236,353
| -57% | -$5.34M |
|
|
EVOP
2182
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $3.44M | ﹤0.01% |
130,270
-63,095
| -33% | -$1.74M |
|
2183
Alaunos Therapeutics
TCRT
$4.86M
| $3.44M | ﹤0.01% |
4,852
-52
| -1% | -$35.8K |
|
2184
Franklin Covey
FC
$246M
| $3.43M | ﹤0.01% |
106,471
+64,818
| +156% | +$2.35M |
|
2185
Unilever
UL
$136B
| $3.43M | ﹤0.01% |
53,332
+97
| +0.2% | +$6.44K |
|
|
AXNX
2186
DELISTED
Axonics, Inc. Common Stock
AXNX
| $3.4M | ﹤0.01% |
122,878
+59,140
| +93% | +$1.41M |
|
2187
Pitney Bowes
PBI
$2.39B
| $3.4M | ﹤0.01% |
844,463
-11,024
| -1% | -$50.5K |
|
2188
Arlo Technologies
ARLO
$1.65B
| $3.4M | ﹤0.01% |
807,072
+382,235
| +90% | +$1.31M |
|
2189
MGP Ingredients
MGPI
$375M
| $3.39M | ﹤0.01% |
69,989
+9,216
| +15% | +$432K |
|
2190
Innovative Industrial Properties
IIPR
$1.72B
| $3.38M | ﹤0.01% |
44,494
-1,269
| -3% | -$98.4K |
|
|
JOBS
2191
DELISTED
51job Inc
JOBS
| $3.37M | ﹤0.01% |
39,720
-92
| -0.2% | -$7.36K |
|
|
CHCT
2192
Community Healthcare Trust
CHCT
$454M
| $3.36M | ﹤0.01% |
78,503
+5,353
| +7% | +$244K |
|
|
MSGN
2193
DELISTED
MSG Networks Inc.
MSGN
| $3.36M | ﹤0.01% |
193,062
-478,126
| -71% | -$7.96M |
|
|
CURO
2194
DELISTED
CURO Group Holdings Corp.
CURO
| $3.35M | ﹤0.01% |
275,509
+33,099
| +14% | +$443K |
|
2195
NRC Health Common Stock
NRC
$450M
| $3.35M | ﹤0.01% |
50,756
-1,119
| -2% | -$68.4K |
|
2196
Gorman-Rupp
GRC
$2.21B
| $3.34M | ﹤0.01% |
89,072
-1,799
| -2% | -$65.5K |
|
|
IMGN
2197
DELISTED
Immunogen Inc
IMGN
| $3.34M | ﹤0.01% |
653,757
-35,188
| -5% | -$119K |
|
|
CPLG
2198
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $3.34M | ﹤0.01% |
312,388
-560
| -0.2% | -$5.65K |
|
|
TRHC
2199
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $3.33M | ﹤0.01% |
68,357
-1,136
| -2% | -$53.2K |
|
|
CIR
2200
DELISTED
CIRCOR International, Inc
CIR
| $3.33M | ﹤0.01% |
71,930
-1,345
| -2% | -$55.6K |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.